| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3936626
[patent_doc_number] => 05871940
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Assays for modulators of drosophila cation channel function'
[patent_app_type] => 1
[patent_app_number] => 8/782396
[patent_app_country] => US
[patent_app_date] => 1997-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 16172
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871940.pdf
[firstpage_image] =>[orig_patent_app_number] => 782396
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/782396 | Assays for modulators of drosophila cation channel function | Jan 12, 1997 | Issued |
Array
(
[id] => 3775148
[patent_doc_number] => 05808002
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Stem cell factor receptor-(c-kit)-specific monoclonal antibody A3C6E2'
[patent_app_type] => 1
[patent_app_number] => 8/778524
[patent_app_country] => US
[patent_app_date] => 1997-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4306
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808002.pdf
[firstpage_image] =>[orig_patent_app_number] => 778524
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/778524 | Stem cell factor receptor-(c-kit)-specific monoclonal antibody A3C6E2 | Jan 2, 1997 | Issued |
| 08/767224 | CLONED GLUCAGON-LIKE PEPTIDE 2 RECEPTORS | Dec 12, 1996 | Abandoned |
Array
(
[id] => 3970561
[patent_doc_number] => 05916559
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-29
[patent_title] => 'Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejection'
[patent_app_type] => 1
[patent_app_number] => 8/761975
[patent_app_country] => US
[patent_app_date] => 1996-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3925
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/916/05916559.pdf
[firstpage_image] =>[orig_patent_app_number] => 761975
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/761975 | Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejection | Dec 10, 1996 | Issued |
| 08/284439 | MOLECULAR CLONING AND EXPRESSION OF A Y-INTERFERON INDUCIBLE ACTIVATOR OF THE PROTEASOME | Dec 8, 1996 | Abandoned |
Array
(
[id] => 3824639
[patent_doc_number] => 05759788
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them'
[patent_app_type] => 1
[patent_app_number] => 8/753985
[patent_app_country] => US
[patent_app_date] => 1996-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 12777
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/759/05759788.pdf
[firstpage_image] =>[orig_patent_app_number] => 753985
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/753985 | High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them | Dec 2, 1996 | Issued |
Array
(
[id] => 3973874
[patent_doc_number] => 05916773
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-29
[patent_title] => 'Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components'
[patent_app_type] => 1
[patent_app_number] => 8/750128
[patent_app_country] => US
[patent_app_date] => 1996-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 4416
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/916/05916773.pdf
[firstpage_image] =>[orig_patent_app_number] => 750128
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/750128 | Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components | Nov 26, 1996 | Issued |
Array
(
[id] => 4043285
[patent_doc_number] => 05874406
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Synthetic peptide analogs of lung surface protein SP-C'
[patent_app_type] => 1
[patent_app_number] => 8/750194
[patent_app_country] => US
[patent_app_date] => 1996-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874406.pdf
[firstpage_image] =>[orig_patent_app_number] => 750194
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/750194 | Synthetic peptide analogs of lung surface protein SP-C | Nov 26, 1996 | Issued |
Array
(
[id] => 3883178
[patent_doc_number] => 05776734
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'DNA encoding the .beta. subunit of a mammalian maxi-K potassium channel'
[patent_app_type] => 1
[patent_app_number] => 8/732506
[patent_app_country] => US
[patent_app_date] => 1996-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14187
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776734.pdf
[firstpage_image] =>[orig_patent_app_number] => 732506
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732506 | DNA encoding the .beta. subunit of a mammalian maxi-K potassium channel | Nov 11, 1996 | Issued |
| 08/742305 | CONTINUOUS LOW-DOSE CYTOKINE INFUSION THERAPY | Oct 31, 1996 | Abandoned |
| 08/571984 | HUMAN GLUCAGON-LIKE 1 PEPTIDE RECEPTOR | Oct 27, 1996 | Abandoned |
| 08/734097 | PURIFIED HUMAN ERYTROPOIETIN RECEPTOR PROTEIN FRAGMENT AND ANTIBODIES DERIVED THEREFROM | Oct 20, 1996 | Abandoned |
Array
(
[id] => 4078984
[patent_doc_number] => RE036713
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'APC gene and nucleic acid probes derived therefrom'
[patent_app_type] => 2
[patent_app_number] => 8/726870
[patent_app_country] => US
[patent_app_date] => 1996-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 42
[patent_no_of_words] => 32471
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/036/RE036713.pdf
[firstpage_image] =>[orig_patent_app_number] => 726870
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/726870 | APC gene and nucleic acid probes derived therefrom | Oct 3, 1996 | Issued |
| 08/721018 | PROTEIN WHICH INDUCES INTERFERON-GAMMA PRODUCTION BY IMMUNOCOMPETENT CELL | Sep 25, 1996 | Abandoned |
Array
(
[id] => 4059408
[patent_doc_number] => 06007805
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'Use of interferon subtype alpha-8 (IFN-.alpha..sub.8) to treat viral infections of the liver'
[patent_app_type] => 1
[patent_app_number] => 8/704784
[patent_app_country] => US
[patent_app_date] => 1996-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 1648
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/007/06007805.pdf
[firstpage_image] =>[orig_patent_app_number] => 704784
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/704784 | Use of interferon subtype alpha-8 (IFN-.alpha..sub.8) to treat viral infections of the liver | Sep 23, 1996 | Issued |
| 08/706958 | GROWTH DIFFERENTIATION FACTOR-11 | Sep 2, 1996 | Abandoned |
Array
(
[id] => 3943162
[patent_doc_number] => 05981714
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/691605
[patent_app_country] => US
[patent_app_date] => 1996-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13266
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981714.pdf
[firstpage_image] =>[orig_patent_app_number] => 691605
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/691605 | Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor | Aug 14, 1996 | Issued |
Array
(
[id] => 3693740
[patent_doc_number] => 05661009
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Recombinant production of consensus human leukocyte interferon'
[patent_app_type] => 1
[patent_app_number] => 8/686822
[patent_app_country] => US
[patent_app_date] => 1996-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 16785
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661009.pdf
[firstpage_image] =>[orig_patent_app_number] => 686822
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/686822 | Recombinant production of consensus human leukocyte interferon | Jul 25, 1996 | Issued |
Array
(
[id] => 3757779
[patent_doc_number] => 05843697
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein'
[patent_app_type] => 1
[patent_app_number] => 8/683743
[patent_app_country] => US
[patent_app_date] => 1996-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 24025
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843697.pdf
[firstpage_image] =>[orig_patent_app_number] => 683743
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/683743 | Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein | Jul 16, 1996 | Issued |
Array
(
[id] => 4040643
[patent_doc_number] => 05874230
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Assays using TRAF2-associated protein kinase polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/677862
[patent_app_country] => US
[patent_app_date] => 1996-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3435
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874230.pdf
[firstpage_image] =>[orig_patent_app_number] => 677862
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/677862 | Assays using TRAF2-associated protein kinase polypeptides | Jul 9, 1996 | Issued |